Discover how IQVIA and Advarra accelerated COVID-19 vaccine trials with IBC approvals in under two days, activating sites 71% faster.
An Institutional Biosafety Committee (IBC) evaluates risks in gene therapy research to ensure safety and compliance with NIH guidelines. Learn when IBC review is needed.
Effective coverage analysis is crucial for billing compliance, helping sites avoid financial penalties and protect their study’s integrity.
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.
Discover how Meridian partnered with Advarra to ensure safety and streamline gene therapy research, including swift IBC approvals in just four days.
While patient recruitment is key to starting a clinical trial, patient retention may be more critical in ensuring the trial
Learn how Advarra’s Budget Negotiation Service helped a site increase funding by 260%, reduce costs, and achieve faster study turnaround times.
Download the case study to see how Advarra Enroll increased ease and efficiency for site prescreening, while providing sponsor teams essential visibility into recruitment progress.
Learn how UChicago Comprehensive Cancer Center streamlined research administration with Advarra EVAL, improving data management and reporting.
Learn how the University of Kentucky Markey Cancer Center utilized OnCore to streamline processes and achieve prestigious NCI designation.
Discover how Atrium Health’s OnCore-EMR integration ensures trial status visibility, improving treatment quality for patients and trial subjects.
Wayne State University simplifies FDA trial compliance by integrating Advarra EDC and Validation Services, reducing reliance on external vendors.
